In October, the world turns pink to raise awareness about the most common type of cancer “Breast cancer” that has affected 2.3 million women around the globe.
Breast cancer is cancer that develops in breast cells. Typically, the cancer forms in either the lobules or the ducts of the breast.
Triple-negative breast cancer (TNBC) is a heterogeneous disease diagnosed by immunohistochemistry and is characterised by tumours that do not express estrogen receptor (ER) or progesterone receptor (PR) at all, and do not overexpress human epidermal growth factor receptor 2 (HER2).
DBS provides a comprehensive breast panel of novel antibodies that ensures high specificity and sensitivity for IHC applications. This allows the oncologists and pathologists to make accurate and rapid diagnosis and choose appropriate path of treatment for the patients.
Order Now: https://bit.ly/3C1nMSw